| Synonyms: | |
| Status: | Approved (2007) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | C07AB12 |
| UNII: | 030Y90569U |
| InChI Key | KOHIRBRYDXPAMZ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C22H25F2NO4 |
| Molecular Weight | 405.44 |
| AlogP | 2.36 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 70.95 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 29.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Auxiliary transport protein
Slow voltage-gated potassium channel accessory protein family
|
- | 15849-39811 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 316-6310 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Voltage-gated calcium channel
|
- | 15849 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | 6310-7943 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hypertension | 3 | D006973 | ClinicalTrials |
| Marfan Syndrome | 3 | D008382 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Essential Hypertension | 2 | D000075222 | ClinicalTrials |
| Stroke | 2 | D020521 | ClinicalTrials |
| Idiopathic Pulmonary Fibrosis | 1 | D054990 | ClinicalTrials |
| Osteoporosis | 0 | D010024 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 118457-14-0 |
| ChEBI | 64019 |
| ChEMBL | CHEMBL434394 |
| DrugBank | DB04861 |
| DrugCentral | 1887 |
| EPA CompTox | DTXSID9040556 |
| FDA SRS | 030Y90569U |
| Human Metabolome Database | HMDB0015594 |
| Guide to Pharmacology | 7246 |
| PharmGKB | PA151958426 |
| SureChEMBL | SCHEMBL19863 |